Dr. Luke Discusses the Combination of Epacadostat and Pembrolizumab in Melanoma

September 9, 2017
Jason J. Luke, MD

Jason J. Luke, MD, assistant professor of Medicine, The University of Chicago Medicine, discusses the combination of epacadostat and pembrolizumab (Keytruda) for the treatment of melanoma during the 2017 ESMO Annual Congress.